Bain Capital Specialty Finance (BCSF)
(Real Time Quote from BATS)
$16.69 USD
+0.04 (0.24%)
Updated Aug 26, 2024 01:08 PM ET
3-Hold of 5 3
B Value B Growth A Momentum A VGM
Income Statements
Fiscal Year end for Bain Capital Specialty Finance, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 298 | 220 | 197 | 194 | 198 |
Cost Of Goods | 0 | 0 | 0 | 0 | 0 |
Gross Profit | 298 | 220 | 197 | 194 | 198 |
Selling & Adminstrative & Depr. & Amort Expenses | 73 | 64 | 68 | 48 | 58 |
Income After Depreciation & Amortization | 225 | 156 | 130 | 146 | 140 |
Non-Operating Income | 0 | 0 | 9 | 3 | 11 |
Interest Expense | 80 | 52 | 51 | 63 | 66 |
Pretax Income | 145 | 104 | 88 | 86 | 85 |
Income Taxes | 3 | 1 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | -14 | -14 | 37 | -62 | 12 |
Other Income/Charges | -4 | 17 | -5 | -16 | 1 |
Income From Cont. Operations | 123 | 105 | 120 | 8 | 98 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 123 | 105 | 120 | 8 | 98 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 223 | 155 | 130 | 143 | 137 |
Depreciation & Amortization (Cash Flow) | -2 | -1 | 0 | -3 | -3 |
Income After Depreciation & Amortization | 225 | 156 | 130 | 146 | 140 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 64.56 | 64.56 | 64.56 | 58.67 | 51.60 |
Diluted EPS Before Non-Recurring Items | 2.19 | 1.59 | 1.36 | 1.46 | 1.64 |
Diluted Net EPS (GAAP) | 1.91 | 1.63 | 1.36 | 0.14 | 1.90 |
Fiscal Year end for Bain Capital Specialty Finance, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 72.27 | 74.50 | 74.95 | 72.39 | 75.72 |
Cost Of Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 72.27 | 74.50 | 74.95 | 72.39 | 75.72 |
SG&A, R&D, and Dept/Amort Expenses | 20.37 | 21.47 | 19.80 | 15.33 | 15.25 |
Income After SG&A, R&D, and Dept/Amort Expenses | 51.90 | 53.03 | 55.15 | 57.06 | 60.47 |
Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 17.63 | 18.06 | 19.22 | 20.78 | 20.46 |
Pretax Income | 34.27 | 34.98 | 35.92 | 36.29 | 40.01 |
Income Taxes | 1.15 | 1.03 | 1.03 | 0.64 | 1.10 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | -4.09 | -1.64 | 1.57 | -7.73 | -8.07 |
Other Income/Charges | 0.06 | 2.78 | -5.41 | 5.93 | -1.67 |
Income From Cont. Operations | 29.09 | 35.10 | 31.06 | 33.86 | 29.17 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 29.09 | 35.10 | 31.06 | 33.86 | 29.17 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 64.56 | 64.56 | 64.72 | 64.56 | 64.56 |
Diluted EPS Before Non-Recurring Items | 0.51 | 0.53 | 0.54 | 0.55 | 0.60 |
Diluted Net EPS (GAAP) | 0.45 | 0.55 | 0.49 | 0.52 | 0.45 |